Intratracheal Dexmedetomidine Versus Lidocaine in Eye Surgery

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 22, 2021

Primary Completion Date

July 1, 2022

Study Completion Date

July 30, 2022

Conditions
Postoperative Complications
Interventions
DRUG

intratracheal saline

At the end of the operation by 15min, 5ml of 0.9% normal saline was sprayed down the intratracheal tube of patients

DRUG

intratracheal Dexmedetomidine

At the end of the operation by 15min, Dexmedetomidine (0.5µg/kg, diluted in 5mL saline in a medical spray bottle) was sprayed down the intratracheal tube of patients

DRUG

intratracheal Lidocaine

At the end of the operation by 15min, (5ml) 2% of lidocaine was sprayed down the intratracheal tube of patients.

Trial Locations (1)

61519

Minya University, Minya

All Listed Sponsors
lead

Minia University

OTHER

NCT05291221 - Intratracheal Dexmedetomidine Versus Lidocaine in Eye Surgery | Biotech Hunter | Biotech Hunter